Global Medical REIT Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Global Medical REITDer Gewinn des Unternehmens wird voraussichtlich um 69.5% pro Jahr sinken, während der Jahresumsatz voraussichtlich um 3.3% pro Jahr wachsen wird. Der Gewinn pro Aktie wird voraussichtlich zurückgehen.

Wichtige Informationen

-65.3%

Wachstumsrate der Gewinne

-72.1%

EPS-Wachstumsrate

Health Care REITs Gewinnwachstum	30.7%
Wachstumsrate der Einnahmen	3.3%
Zukünftige Eigenkapitalrendite	n/a
Analystenabdeckung	Low
Zuletzt aktualisiert	07 Jun 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Global Medical: The 9.5% Yield Appears Covered Despite Pressure From Interest Rates

Jun 29

If EPS Growth Is Important To You, Global Medical REIT (NYSE:GMRE) Presents An Opportunity

Mar 13

Global Medical REIT: A Strong Buy At Attractive Valuations And 7.8% Dividend Yield

Jan 27

Global Medical REIT: Brace For A Hawkish Fed

Dec 25

Global Medical REIT GAAP EPS of $0.12

Nov 02

Global Medical REIT: Passive Income Machine With Safe 10.8% Yield

Oct 21

Global Medical REIT stock drops after BMO downgrades on elevated leverage

Oct 06

Global Medical REIT Now Has A 9% Recession Resistant Yield

Sep 28

Global Medical REIT declares $0.21 dividend

Sep 09

Global Medical REIT: Significant Upside Potential, Along With A High Yielding Dividend

Aug 18

Global Medical REIT: Market Dislocation From First To Worst, Opportunity Refreshed

Jun 29

Global Medical REIT: Another Solid Quarter From This Growing Healthcare REIT

May 17

Global Medical REIT: A Breakdown Of My Favorite Healthcare REIT

Mar 03

Gewinn- und Umsatzwachstumsprognosen

NYSE:GMRE - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	154	3	N/A	N/A	2
12/31/2025	146	3	N/A	N/A	4
12/31/2024	139	2	N/A	N/A	5
3/31/2024	140	15	67	67	N/A
12/31/2023	141	15	68	68	N/A
9/30/2023	144	16	69	69	N/A
6/30/2023	144	21	70	70	N/A
3/31/2023	142	11	76	76	N/A
12/31/2022	137	13	77	77	N/A
9/30/2022	131	17	76	76	N/A
6/30/2022	126	12	76	76	N/A
3/31/2022	120	13	70	70	N/A
12/31/2021	116	12	69	69	N/A
9/30/2021	111	9	68	68	N/A
6/30/2021	106	-5	44	44	N/A
3/31/2021	99	-7	38	38	N/A
12/31/2020	94	-8	35	35	N/A
9/30/2020	89	-8	28	28	N/A
6/30/2020	82	3	44	44	N/A
3/31/2020	77	4	43	43	N/A
12/31/2019	71	3	36	36	N/A
9/30/2019	65	9	32	32	N/A
6/30/2019	60	9	27	27	N/A
3/31/2019	57	8	22	22	N/A
12/31/2018	53	8	25	25	N/A
9/30/2018	49	0	23	23	N/A
6/30/2018	43	1	22	22	N/A
3/31/2018	37	0	19	19	N/A
12/31/2017	30	-2	N/A	13	N/A
9/30/2017	24	-3	N/A	8	N/A
6/30/2017	17	-6	N/A	3	N/A
3/31/2017	12	-6	N/A	2	N/A
12/31/2016	8	-6	N/A	-2	N/A
9/30/2016	6	-5	N/A	-2	N/A
6/30/2016	4	-4	N/A	0	N/A
3/31/2016	3	-3	N/A	-1	N/A
12/31/2015	2	-2	N/A	0	N/A
9/30/2015	3	-1	N/A	0	N/A
6/30/2015	3	-1	N/A	1	N/A
3/31/2015	2	-1	N/A	0	N/A
12/31/2014	2	-1	N/A	0	N/A
11/30/2014	1	-1	N/A	0	N/A
8/31/2014	0	-1	N/A	0	N/A
5/31/2014	N/A	0	N/A	0	N/A
2/28/2014	N/A	0	N/A	0	N/A
11/30/2013	N/A	0	N/A	0	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: GMREFür die nächsten 3 Jahre wird ein Rückgang der Gewinne prognostiziert (-69.5% pro Jahr).

Ertrag vs. Markt: GMREFür die nächsten 3 Jahre wird ein Rückgang der Gewinne prognostiziert (-69.5% pro Jahr).

Hohe Wachstumserträge: GMREFür die nächsten 3 Jahre wird mit einem Rückgang der Erträge gerechnet.

Einnahmen vs. Markt: GMREDie Einnahmen des Unternehmens (3.3% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.7% pro Jahr).

Hohe Wachstumseinnahmen: GMREDie Einnahmen des Unternehmens (3.3% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von GMRE in 3 Jahren voraussichtlich hoch sein wird

Global Medical REIT Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Consensus EPS estimates fall by 56%, revenue upgraded

Consensus EPS estimates fall by 22%

Consensus EPS estimates increase by 27%

Consensus EPS estimates increase by 25%

Consensus EPS estimates increase by 132%

Price target increased by 8.4% to US$11.34

Recent updates

Global Medical: The Yield Is Not Too Good To Be True

First quarter dividend of US$0.21 announced

Global Medical REIT Inc. Declares 2024 Second Quarter Common Dividend, Payable on July 9, 2024

Global Medical: The 7.6% Preferred Yield Trumps The Common

Consensus EPS estimates fall by 56%, revenue upgraded

Global Medical REIT: Better Q1 Than Expected, But Still A Cautious Stance

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Global Medical REIT Inc. to Report Q1, 2024 Results on May 07, 2024

Upcoming dividend of US$0.21 per share

Fourth quarter dividend of US$0.21 announced

Global Medical REIT Offers A 9.3% Dividend Yield And 7.6% On The Preferreds

Global Medical REIT Inc. Declares Cash Dividend for the First Quarter 2024, Payable on April 9, 2024

Consensus EPS estimates fall by 22%

Full year 2023 earnings: EPS and revenues miss analyst expectations

Global Medical REIT: Nothing Promising After Q4 Results, Still A Hold

Global Medical REIT Inc., Annual General Meeting, May 15, 2024

Global Medical REIT Inc. to Report Q4, 2023 Results on Feb 27, 2024

Global Medical REIT: Patient In Stable Condition, Risk Priced In

Global Medical REIT Inc. has filed a Follow-on Equity Offering in the amount of $300 million.

Upcoming dividend of US$0.21 per share at 7.7% yield

Global Medical REIT Inc. Declares 2023 Fourth Quarter Common Stock Dividend, Payable on January 9, 2024

Global Medical REIT: A Hold Despite Improving Performance

Consensus EPS estimates increase by 27%

Consensus EPS estimates increase by 25%

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Global Medical REIT Inc. to Report Q3, 2023 Results on Nov 06, 2023

Global Medical: 7.7% Yielding Preferreds Are Expensive, A Look At Alternatives

Upcoming dividend of US$0.21 per share at 8.8% yield

Global Medical REIT: Revisiting Dividend Assumption After Q2 Results

Global Medical Reit Inc. Declares the Cash Dividend for Third Quarter 2023 ,Payable on October 10, 2023

New major risk - Revenue and earnings growth

Consensus EPS estimates increase by 132%

Global Medical REIT: Higher For Longer Scenarios Will Stress The REIT

Second quarter 2023 earnings: EPS exceeds analyst expectations

An unknown buyer acquired Medical office building located in North Charleston, South Carolina from Global Medical REIT Inc. (NYSE:GMRE) for $10.1 million.

Global Medical REIT Inc. to Report Q2, 2023 Results on Aug 02, 2023

Price target increased by 8.4% to US$11.34

Global Medical: The 9.5% Yield Appears Covered Despite Pressure From Interest Rates

Upcoming dividend of US$0.21 per share at 8.9% yield

Global Medical REIT Inc. Announces 2023 Second Quarter Common Dividend, Payable on July 11, 2023

Price target decreased by 9.0% to US$10.46

Consensus EPS estimates fall by 23%

Consensus EPS estimates increase by 54%, revenue downgraded

An unknown buyer acquired One medical office building located in Jacksonville, Florida from Global Medical REIT Inc. (NYSE:GMRE) for $4.4 million .

First quarter 2023 earnings: EPS misses analyst expectations

Upcoming dividend of US$0.21 per share at 8.9% yield

If EPS Growth Is Important To You, Global Medical REIT (NYSE:GMRE) Presents An Opportunity

Consensus EPS estimates fall by 52%, revenue upgraded

Full year 2022 earnings: EPS misses analyst expectations

Global Medical REIT Inc. to Report Q4, 2022 Results on Feb 28, 2023

Global Medical REIT: A Strong Buy At Attractive Valuations And 7.8% Dividend Yield

Global Medical REIT Inc. Announces Retirement of Roscoe Moore, Jr. as Director

Global Medical REIT: Brace For A Hawkish Fed

Upcoming dividend of US$0.21 per share

Global Medical REIT Inc. Declares Fourth Quarter Common Dividends, Payable on January 31, 2023

Price target decreased to US$11.57

Insufficient new directors

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Global Medical REIT GAAP EPS of $0.12

Investor sentiment improved over the past week

Global Medical REIT: Passive Income Machine With Safe 10.8% Yield

Consensus forecasts updated

Global Medical REIT Inc. to Report Q3, 2022 Results on Nov 02, 2022

Investor sentiment deteriorated over the past week

Price target decreased to US$13.75

Global Medical REIT stock drops after BMO downgrades on elevated leverage

Global Medical REIT Now Has A 9% Recession Resistant Yield

Investor sentiment deteriorated over the past week

Upcoming dividend of US$0.21 per share